INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2010

Oral curcumin-phosphatidylcholine complex was linked to reduced relapse frequency in patients with recurrent anterior uveitis.

This study evaluated adjunctive treatment with Norflo tablets (curcumin-phosphatidylcholine complex; Meriva) given twice daily for 12 months in 106 patients with recurrent anterior uveitis categorized into three etiological groups. The primary endpoint of relapse frequency showed a statistically significant reduction before versus after treatment across all groups (P < 0.001). Additionally, the treatment was well tolerated and reduced eye discomfort signs and symptoms after a few weeks in more than 80% of patients.

Study type
Interventional follow-up study
Who was studied
106 patients with recurrent anterior uveitis of different etiologies
What was measured
Relapse frequency, relapse severity, and overall quality of life

THE PAPER

Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up.

Allegri P, Mastromarino A, Neri P. Clin Ophthalmol, 2010.

PubMed 21060672 ↗DOI 10.2147/opth.s13271 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.